In clinics, IV dressings are integral components of the market, serving essential functions in patient care. These dressings provide a protective barrier over intravenous access points, safeguarding against infection and minimizing the risk of contamination. They ensure the secure attachment of IV catheters, preventing accidental dislodgement and maintaining the continuity of treatment delivery. Therefore, the Clinics in Germany consumed 847.8 thousand units in 2023.
The Germany market dominated the Europe IV Dressing Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $77.4 Million by 2031. The UK market is exhibiting a CAGR of 4.5% during (2024 - 2031). Additionally, The France market would experience a CAGR of 6.3% during (2024 - 2031).
These dressings are crucial in securing IV catheters and preventing accidental dislodgment or movement that can lead to complications or treatment interruption. They provide stability and support to the catheter, ensuring uninterrupted delivery of medications and fluids. High-quality dressings are designed to be comfort table for patients, minimizing discomfort and irritation at the insertion site. They are typically breathable and flexible, providing ease of movement and reducing the risk of skin irritation or allergic reactions.
Furthermore, some dressings incorporate advanced moisture management technology to absorb excess exudate from the wound site while maintaining an optimal moisture level for healing. This helps to prevent maceration of the surrounding skin and promotes a healthy healing environment. Transparent allow healthcare providers to monitor the insertion site without needing frequent dressing changes. This visibility enables early detection of complications such as infiltration, phlebitis, or signs of infection.
Senior citizens in the UK are more prone to health issues that may necessitate hospitalization, such as cardiovascular diseases, respiratory conditions, and infections. As per the UK government’s report named “Future of an aging population,” by 2040, nearly one in seven people is projected to be over 75. By 2037, there are projected to be 1.42 million more households headed by someone aged 85 or over, an increase of 161% over 25 years. The proportion of the working-age population aged between 50 and the state pension age (SPA) will increase from 26% in 2012 to 34% in 2050, an increase of over 5.5 million people. Thus, all these factors will uplift the regional market’s expansion in the coming years.
Based on Type, the market is segmented into Transparent, and Translucent. Based on End-use, the market is segmented into Hospitals, Clinics, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- 3M Company
- Cardinal Health, Inc.
- Smith & Nephew PLC
- McKesson Corporation
- Covalon Technologies Ltd.
- Becton, Dickinson, and Company
- Molnlycke Health Care AB
- DermaRite Industries, LLC
- Dynarex Corporation
- Essity AB (BSN medical)
Market Report Segmentation
By Type (Volume, Thousand Units, USD Billion, 2020-2031)- Transparent
- Translucent
- Hospitals
- Clinics
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Table of Contents
Companies Mentioned
- 3M Company
- Cardinal Health, Inc.
- Smith & Nephew PLC
- McKesson Corporation
- Covalon Technologies Ltd.
- Becton, Dickinson, and Company
- Molnlycke Health Care AB
- DermaRite Industries, LLC
- Dynarex Corporation
- Essity AB (BSN medical)
Methodology
LOADING...